Baker Tiffany G, Roy Soumen, Brandon Carlene S, Kramarenko Inga K, Francis Shimon P, Taleb Mona, Marshall Keely M, Schwendener Reto, Lee Fu-Shing, Cunningham Lisa L
Department of Pathology and Laboratory Medicine, Medical University of South Carolina, 165 Ashley Ave, Charleston, SC, 29425, USA.
J Assoc Res Otolaryngol. 2015 Feb;16(1):67-80. doi: 10.1007/s10162-014-0491-7. Epub 2014 Sep 27.
Cisplatin is a highly successful and widely used chemotherapy for the treatment of various solid malignancies in both adult and pediatric patients. Side effects of cisplatin treatment include nephrotoxicity and ototoxicity. Cisplatin ototoxicity results from damage to and death of cells in the inner ear, including sensory hair cells. We showed previously that heat shock inhibits cisplatin-induced hair cell death in whole-organ cultures of utricles from adult mice. Since heat shock protein 70 (HSP70) is the most upregulated HSP in response to heat shock, we investigated the role of HSP70 as a potential protectant against cisplatin-induced hair cell death. Our data using utricles from HSP70 (-/-) mice indicate that HSP70 is necessary for the protective effect of heat shock against cisplatin-induced hair cell death. In addition, constitutive expression of inducible HSP70 offered modest protection against cisplatin-induced hair cell death. We also examined a second heat-inducible protein, heme oxygenase-1 (HO-1, also called HSP32). HO-1 is an enzyme responsible for the catabolism of free heme. We previously showed that induction of HO-1 using cobalt protoporphyrin IX (CoPPIX) inhibits aminoglycoside-induced hair cell death. Here, we show that HO-1 also offers significant protection against cisplatin-induced hair cell death. HO-1 induction occurred primarily in resident macrophages, with no detectable expression in hair cells or supporting cells. Depletion of macrophages from utricles abolished the protective effect of HO-1 induction. Together, our data indicate that HSP induction protects against cisplatin-induced hair cell death, and they suggest that resident macrophages mediate the protective effect of HO-1 induction.
顺铂是一种非常成功且广泛应用于治疗成人和儿童各种实体恶性肿瘤的化疗药物。顺铂治疗的副作用包括肾毒性和耳毒性。顺铂耳毒性是由内耳细胞(包括感觉毛细胞)的损伤和死亡引起的。我们之前表明,热休克可抑制成年小鼠椭圆囊全器官培养物中顺铂诱导的毛细胞死亡。由于热休克蛋白70(HSP70)是热休克反应中上调最多的热休克蛋白,我们研究了HSP70作为对抗顺铂诱导的毛细胞死亡的潜在保护剂的作用。我们使用来自HSP70(-/-)小鼠的椭圆囊的数据表明,HSP70对于热休克对顺铂诱导的毛细胞死亡的保护作用是必需的。此外,诱导型HSP70的组成型表达对顺铂诱导的毛细胞死亡提供了适度的保护。我们还研究了另一种热诱导蛋白血红素加氧酶-1(HO-1,也称为HSP32)。HO-1是一种负责游离血红素分解代谢的酶。我们之前表明,使用钴原卟啉IX(CoPPIX)诱导HO-1可抑制氨基糖苷类诱导的毛细胞死亡。在这里,我们表明HO-1也对顺铂诱导的毛细胞死亡提供了显著的保护。HO-1的诱导主要发生在驻留巨噬细胞中,在毛细胞或支持细胞中未检测到表达。从椭圆囊中耗尽巨噬细胞消除了HO-1诱导的保护作用。总之,我们的数据表明热休克蛋白的诱导可保护免受顺铂诱导的毛细胞死亡,并且表明驻留巨噬细胞介导了HO-1诱导的保护作用。